Skip to main content
. 2023 Oct 18;14(12):2159–2172. doi: 10.1007/s13300-023-01490-6

Fig. 2.

Fig. 2

Reasons for choosing oral semaglutide by ongoing glucose-lowering regimen. Note: Arrows are reported when the difference between the reported variable in the specific group is significant compared to that in the remaining population. Arrows with asterisk: significant vs overall with study-wide significance p < 0.0005; regular arrows: significant vs overall with nominal p < 0.05